Products
Platform
Research
Market
Learn
Piramal Pharma Ltd Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Consolidate
Standalone
Total Qtr Revenue cr | 2,109.32 | 1,992.11 | 2,796.10 | 2,216.35 | 2,302.86 |
| Other Income Qtr Cr | 65.60 | 58.40 | 42.03 | 12.13 | 61.11 |
| Operating Revenues Qtr | 2,043.72 | 1,933.71 | 2,754.07 | 2,204.22 | 2,241.75 |
Loading chart... | |||||
Operating Expenses Qtr | 1,885.03 | 1,827.01 | 2,193.08 | 1,866.48 | 1,900.14 |
Operating Profit Qtr | 158.69 | 106.70 | 560.99 | 337.74 | 341.61 |
EBITDA Qtr Cr | 224.29 | 185.84 | 603.02 | 349.87 | 402.72 |
Depreciation Qtr | 202.84 | 197.28 | 242.76 | 196.81 | 192.22 |
Net Profit Qtr | -99.22 | -81.70 | 153.50 | 3.68 | 22.59 |
Basic EPS Qtr | -0.75 | -0.62 | 1.16 | 0.03 | 0.17 |
Open Demat Account
Open Demat Account